Form 4: Immunome Executive Receives Stock Grant
Insider Transaction (Form 4)
Sandra G. Stoneman, CHIEF LEGAL OFFICER & GC of Immunome Inc., reported multiple transactions in common stock on July 23, 2026.
Summary
- Grant/award: acquired 38,250 Common Stock on July 23, 2026; holds 43,805 after (Direct).
- Grant/award: acquired 76,500 Employee Stock Option (right to buy) on July 23, 2026; holds 76,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sandra G. Stoneman — Officer (CHIEF LEGAL OFFICER & GC)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Grant/award | Common Stock | 38,250 | — | — | 43,805 |
| 2026-07-23 | Grant/award | Employee Stock Option (right to buy) | 76,500 | — | — | 76,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Grant/award (38,250 shares) |
| 2026-07-23 | Grant/award (76,500 shares) |
Keywords
insider transaction, Form 4, IMNM, Immunome Inc., neutral, Sandra G. Stoneman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.